Profiel
Sean McAuliffe is currently the Chief Business Officer at Taysha Gene Therapies, Inc. Prior to his current position, he served as the Vice President-Marketing at Novartis Gene Therapies, Inc. from 2018 to 2020.
Actieve functies van Sean McAuliffe
| Bedrijven | Functie | Begin |
|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Corporate Officer/Principal | 01-06-2020 |
Eerdere bekende functies van Sean McAuliffe
| Bedrijven | Functie | Einde |
|---|---|---|
| AVEXIS INC | Sales & Marketing | 01-06-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TAYSHA GENE THERAPIES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
